Tirzepatide
Tirzepatide is a next-generation dual-action peptide that activates both GLP-1 and GIP receptors to enhance glucose regulation and promote substantial fat loss. Initially developed for type 2 diabetes management, Tirzepatide has quickly gained recognition in medical weight loss programs for its unmatched ability to curb appetite, improve insulin sensitivity, and promote metabolic efficiency.
Its unique dual-receptor activity offers deeper and more sustained effects compared to traditional GLP-1 agonists. Users commonly experience reduced cravings, stable blood sugar levels, increased energy, and consistent weight reduction when used under professional guidance.
Product Highlights
Dosing Instructions
Reconstitute peptide with bacteriostatic water. Administer subcutaneously in the abdomen, thigh, or upper arm once weekly. Begin with the lowest available dose and titrate gradually as tolerated.
Compound Information
Primary Use: Type 2 diabetes management and obesity treatment.
Class: Dual GIP and GLP-1 receptor agonist.
Molecular Weight: ~4,814 Da.
Formula: C225H348N48O68.
Mechanism: Activates GIP and GLP-1 receptors to improve insulin sensitivity and reduce appetite.
Administration: Subcutaneous injection, once weekly.
Half-Life: ~5 days.
Note: All peptide products are for research purposes only. Information provided is educational and not a substitute for medical advice.
Reviews
There are no reviews yet.